Publications

Publications (original articles or review articles) published in 2009 from OUS - Department of Nephrology Rikshospitalet

30 publications found

Abedini S, Holme I, Fellström B, Jardine A, Cole E, Maes B, Holdaas H, ALERT Study Group (2009)
Cerebrovascular events in renal transplant recipients
Transplantation, 87 (1), 112-7
PubMed 19136900

Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A, Cole E, Maes B, Neumayer HH, Grønhagen-Riska C, Ambühl P, Holdaas H, ALERT study group (2009)
Inflammation in renal transplantation
Clin J Am Soc Nephrol, 4 (7), 1246-54
PubMed 19541816

Amundsen R, Asberg A, Robertsen I, Vethe NT, Bergan S, Hartmann A, Midtvedt K (2009)
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients
Transplantation, 87 (8), 1221-4
PubMed 19384170

Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Mørkrid L, Jenssen T, Hartmann A (2009)
Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
Clin Transplant, 23 (4), 511-8
PubMed 19210527

Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A (2009)
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
Antivir Ther, 14 (5), 697-704
PubMed 19704173

Bremer S, Vethe NT, Rootwelt H, Jørgensen PF, Stenstrøm J, Holdaas H, Midtvedt K, Bergan S (2009)
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study
J Transl Med, 7, 64
PubMed 19635156

Dolgos S, Hartmann A, Bønsnes S, Isaksen GA, Godang K, Ueland T, Pfeffer P, Bollerslev J (2009)
Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation
Scand J Clin Lab Invest, 69 (2), 161-7
PubMed 18972258

Dolgos S, Hartmann A, Jenssen T, Isaksen GA, Pfeffer P, Bollerslev J (2009)
Determinants of short-term changes in body composition following renal transplantation
Scand J Urol Nephrol, 43 (1), 76-83
PubMed 18777442

Falck P, Midtvedt K, Vân Lê TT, Storehagen L, Holdaas H, Hartmann A, Asberg A (2009)
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients
Clin Pharmacokinet, 48 (9), 615-23
PubMed 19725595

Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F, AURORA Study Group (2009)
Cardiovascular disease in patients with renal disease: the role of statins
Curr Med Res Opin, 25 (1), 271-85
PubMed 19210158

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP et al. (2009)
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
N Engl J Med, 360 (14), 1395-407
PubMed 19332456

Foss A, Heldal K, Scott H, Foss S, Leivestad T, Jørgensen PF, Scholz T, Midtvedt K (2009)
Kidneys from deceased donors more than 75 years perform acceptably after transplantation
Transplantation, 87 (10), 1437-41
PubMed 19461478

Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K (2009)
Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity
Transplantation, 87 (7), 1045-51
PubMed 19352126

Hjelmesaeth J, Hofsø D, Aasheim ET, Jenssen T, Moan J, Hager H, Røislien J, Bollerslev J (2009)
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study
Cardiovasc Diabetol, 8, 7
PubMed 19187564

Hofsø D, Jenssen T, Bollerslev J, Røislien J, Hager H, Hjelmesaeth J (2009)
Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study
Diabetes Res Clin Pract, 86 (1), e9-11
PubMed 19608292

Hofsø D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, Aukrust P, Røislien J, Hjelmesaeth J (2009)
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
Eur J Endocrinol, 161 (3), 451-8
PubMed 19542241

Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A (2009)
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease
Clin Infect Dis, 49 (8), 1160-6
PubMed 19751151

Mjøen G, Øyen O, Holdaas H, Midtvedt K, Line PD (2009)
Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry
Transplantation, 88 (11), 1273-9
PubMed 19996926

Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group (2009)
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study
Arthritis Rheum, 60 (4), 1060-4
PubMed 19333947

Reisaeter AV, Røislien J, Henriksen T, Irgens LM, Hartmann A (2009)
Pregnancy and birth after kidney donation: the Norwegian experience
Am J Transplant, 9 (4), 820-4
PubMed 18853953

Richard Hobbs FD, Gensini G, John Mancini GB, Manolis AJ, Bauer B, Genest J, Feldman RD, Harvey P, Jenssen TG, da Silva PM, JEWEL Study Group (2009)
International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme
Eur J Cardiovasc Prev Rehabil, 16 (4), 472-80
PubMed 19407658

Skottheim IB, Stormark K, Christensen H, Jakobsen GS, Hjelmesaeth J, Jenssen T, Reubsaet JL, Sandbu R, Asberg A (2009)
Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients
Clin Pharmacol Ther, 86 (3), 311-8
PubMed 19494810

Solbu MD, Jenssen TG, Eriksen BO, Toft I (2009)
Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study
Metabolism, 58 (3), 408-15
PubMed 19217459

Solbu MD, Kronborg J, Jenssen TG, Njølstad I, Løchen ML, Mathiesen EB, Wilsgaard T, Eriksen BO, Toft I (2009)
Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events
Atherosclerosis, 204 (2), 503-8
PubMed 19091314

Soveri I, Abedini S, Holdaas H, Jardine A, Eriksson N, Fellström B (2009)
Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment
Clin Transplant, 23 (6), 914-20
PubMed 19594771

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation
Transplantation, 88 (3), 429-34
PubMed 19667949

Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
Experience from an active preemptive kidney transplantation program--809 cases revisited
Transplantation, 88 (5), 672-7
PubMed 19741464

Aasebø W (2009)
ECG-voltage in alcoholics and non-alcoholics with acute alcohol intoxication
J Forensic Leg Med, 16 (7), 381-4
PubMed 19733325

Aasebø W, Hartmann A, Jenssen T (2009)
Predictors of anemia in patients on hemodialysis
Hemodial Int, 13 (3), 335-9
PubMed 19614760

Aasebø W, Homb-Vesteraas NA, Hartmann A, Stavem K (2009)
Life situation and quality of life in young adult kidney transplant recipients
Nephrol Dial Transplant, 24 (1), 304-8
PubMed 18840897